Daiichi Pharmaceutical - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsDaiichi Pharmaceutical

Daiichi Pharmaceutical

Daiichi Sankyo Company, Limited (Japanese: 第一三共株式会社, Hepburn: Daiichi Sankyō Kabushiki-gaisha) is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 981.8 billion in revenue in 2019. The company owns the American biotechnology company Plexxikon, American pharmaceutical company American Regent, German biotechnology company U3 Pharma, and recently sold Ranbaxy Laboratories in India. Daiichi Sankyo Co., Ltd. is the producer of Benicar (Olmesartan), an angiotensin II receptor antagonist and top selling drug in the U.S. Global sales of Olmesartan in 2013 were 300.2 billion yen.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Enhertu	Trastuzumab deruxtecan	2019-12-20		Breast neoplasms , Gastrointestinal neoplasms
Floxin	Ofloxacin	1997-12-16		Corneal ulcer , Prostatitis , Pulmonary tuberculosis , Urinary tract infections , Bacterial infections , Gonorrhea , Bacterial skin diseases , Escherichia coli infections , Soft tissue infections , Chlamydia infections , Helicobacter infections , Bronchitis , Bacterial conjunctivitis , Suppurative otitis media , Staphylococcal infections , Salmonella infections , Proteus infections , Klebsiella infections , Otitis externa , Haemophilus infections , Protozoan infections , Cystitis , Epididymitis
Lixiana	Edoxaban	2015-06-19	2027-2028	Venous thromboembolism , Stroke , Venous thrombosis , Pulmonary embolism
Nilemdo	Bempedoic acid	2020-04-01	2025-2040	Hypercholesterolemia, Dyslipidemias, Atherosclerosis, Hyperlipoproteinemia type ii, Familial combined hyperlipidemia
Nustendi	Bempedoic acid, Ezetimibe	2020-03-27	2025-2040	Hypercholesterolemia, Dyslipidemias, Atherosclerosis, Hyperlipoproteinemia type ii, Familial combined hyperlipidemia
Savaysa	Edoxaban	2015-01-08	2027-2028	Venous thromboembolism, Stroke, Venous thrombosis, Pulmonary embolism
Turalio	Pexidartinib	2019-08-02	2027-2038	Giant cell tumor of tendon sheath
Vanflyta	Quizartinib	2023-07-20	2027-2033	Myeloid leukemia acute, Myeloid leukemia

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Trastuzumab deruxtecan

breast neoplasms

coagulation protein disorders

,

pancreatic neoplasms

,

bariatric surgery

,

healthy volunteers/patients

,

peripheral arterial disease

,

blood coagulation

,

replacement arthroplasty hip

,

peripheral vascular diseases

,

,

,

embolism and thrombosis

,

replacement arthroplasty knee

,

pathologic constriction

,

mitral valve stenosis

,

liver cirrhosis

,

,

,

,

traumatic intracranial hemorrhage

,

renal insufficiency

,

wounds and injuries

,

cerebral hemorrhage

,

subdural hematoma

,

,

cerebrovascular disorders

,

hypertensive intracranial hemorrhage

,

subarachnoid hemorrhage

,

cerebral intraventricular hemorrhage

,

cerebral small vessel diseases

,

electric countershock

,

severe acute respiratory syndrome

,

,

,

atrial fibrillation

,

thromboembolism

,

,

venous thromboembolism

,

,

,

ischemic stroke

,

venous thrombosis

,

,

,

pulmonary embolism

,

coronary artery disease

,

blood coagulation disorders

,

hemostatic disorders

,

,

cerebral infarction

,

intracranial hemorrhages

,

myocardial ischemia

,

coronary disease

,

,

drug-related side effects and adverse reactions

,

aortic valve stenosis

,

myocardial infarction

,

,

atherosclerosis

,

,

cognitive dysfunction

,

diabetes mellitus

,

transcatheter aortic valve replacement

,

ventricular tachycardia

,

,

ventricular premature complexes

,

acute coronary syndrome

,

st elevation myocardial infarction

,

,

angina pectoris

,

,

chronic renal insufficiency

,

kidney diseases

,

,

communicable diseases

,

staphylococcal infections

,

,

,

heart valve diseases

,

postphlebitic syndrome

,

postthrombotic syndrome

,

,

arterial occlusive diseases

,

postoperative complications

,

pulmonary hypertension

,

vascular diseases

,

,

,

oral surgical procedures

,

,

antiphospholipid syndrome

,

myeloproliferative disorders

,

craniocerebral trauma

,

,

intracranial thrombosis

,

retinal vein occlusion

,

,

pharmacokinetics

,

intracranial arteriosclerosis

,

,

,

subdural hematoma chronic

,

,

drug interactions

,

capillary fragility

,

cardiovascular diseases

,

aortic valve disease

,

aortic diseases

,

genetic polymorphism

,

keratoconjunctivitis sicca

,

dry eye syndromes

healthy volunteers/patients

,

pharmacokinetics

,

drug interactions

,

,

hepatic insufficiency

,

,

myelodysplastic syndromes

,

,

myeloid leukemia acute

,

myeloid leukemia

type 2 diabetes mellitus

,

,

metabolic diseases

,

metabolic syndrome

,

metabolic brain diseases

,

diabetes mellitus

,

,

,

left ventricular hypertrophy

,

,

,

essential hypertension

,

kidney diseases

,

rectal diseases

cardiovascular diseases

,

,

,

acute lung injury

,

Hyaluronate sodium

erectile dysfunction

,

,

dry eye syndromes

,

keratoconjunctivitis sicca

,

,

allergic conjunctivitis

,

,

angle-closure glaucoma

,

intraocular pressure

,

meibomian gland dysfunction

mucocutaneous lymph node syndrome

,

,

,

female genital neoplasms

,

drug-related side effects and adverse reactions

,

uterine cervical neoplasms

,

cholangiocarcinoma

,

ischemic stroke

,

,

patent foramen ovale

,

atrial fibrillation

,

thromboembolism

Fam-trastuzumab deruxtecan-nxki

prostatic neoplasms

,

breast neoplasms

,

brain neoplasms

,

neoplasm metastasis

1

2

3

4

5

6

...

10

>

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use